IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$3.08
52W Range
$2.12 - $42.00
50D Avg
$4.95
200D Avg
$14.73
Market Cap
$6.49M
Avg Vol (3M)
$3.38M
Beta
1.54
Div Yield
-
ICCM Company Profile
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.